Richard Makara - 15 Jun 2022 Form 4 Insider Report for Cara Therapeutics, Inc. (TVRD)

Reporting relationship: VP, Head of Accting;Controller
Issuer ticker: TVRD
Reported as of: 15 Jun 2022
Net transaction value: $0
SEC form: 4
Accepted by SEC: 16 Jun 2022, 17:14:11 UTC
Source filing: View source filing
Reporting owner signature: /s/ Darren DeStefano, Attorney-in-Fact

Key filing fact

Richard Makara filed Form 4 for Cara Therapeutics, Inc. (TVRD) on 16 Jun 2022.

Key facts

This page summarizes Richard Makara's Form 4 filing for Cara Therapeutics, Inc. (TVRD).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 16 Jun 2022, 17:14.

Change

No earlier filing in this sequence is available for direct comparison.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

CARA transaction

Common Stock

Award

Transaction value: $0
Shares: +7,500
Change %: +123%
Price: $0.000000
Shares after: 13,583
Date: 15 Jun 2022
Ownership: Direct
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Represents restricted stock units ("RSUs"). Each RSU represents the contingent right to receive one share of common stock of the Issuer. The RSUs will vest on the earlier of (i) December 31, 2022, or (ii) the appointment of the Issuer's new Chief Financial Officer, subject to the Reporting Person's continued service to the Issuer as of such vesting date.